乳腺导管内癌外科治疗与预后:526例分析
该回顾性研究分析526例乳腺导管内癌(DCIS)患者,77.0%行乳房切除术,23.0%行保乳手术(其中88例术后放疗)。年龄>50岁、首发乳头溢液、切除活检及病灶>3 cm与乳房手术方式独立相关,不同术式5年无病生存率与总体生存率差异无统计学意义。
要点
- 年龄>50岁、乳头溢液、切除活检及病灶>3 cm是DCIS乳房手术方式的独立预测因素。
- 腋窝淋巴结评估方式受年龄、活检方式、乳房手术方式及病灶最大径影响。
- 乳房切除、保乳及保乳+放疗三组5年生存差异无统计学意义。
核心结论
- 年龄、首发症状及病灶最大径是DCIS患者乳房手术方式选择的独立预后因素。
- 腋窝淋巴结评估方式选择受患者年龄、活检方式、乳房手术方式及病灶最大径影响。
- 不同局部治疗方式对DCIS患者无病生存率及总体生存率无明显影响。
研究设计与样本
- 回顾性分析2009年1月至2016年8月上海交通大学医学院附属瑞金医院乳腺疾病诊治中心手术治疗的DCIS患者526例。
- 采用χ²检验、Logistic回归分析手术方式影响因素,Kaplan-Meier法及Log-rank法比较生存差异。
主要发现
- 405例(77.0%)接受乳房切除术,121例(23.0%)接受保乳手术,其中88例保乳术后放疗。
- 年龄>50岁(OR=0.631,95%CI:0.413~0.965,P=0.034)、首发乳头溢液(OR=0.316,95%CI:0.120~0.834,P=0.020)、切除活检(OR=1.831,95%CI:1.182~2.835,P=0.007)及病灶最大径>3 cm(OR=0.422,95%CI:0.206~0.864,P=0.018)与乳房手术方式显著相关。
- 腋窝淋巴结清扫118例(22.4%),前哨淋巴结活检327例(62.2%),未行腋窝手术81例(15.4%)。
- 腋窝淋巴结评估方式选择受年龄(χ²=8.124,P=0.017)、活检方式(χ²=35.567,P=0.000)、乳房手术方式(χ²=149.118,P=0.000)及病灶最大径(χ²=13.394,P=0.010)影响。
- 乳房切除术组、保乳+放疗组、保乳组5年无病生存率分别为95.7%、89.6%、100%,5年总体生存率分别为99.0%、100%、100%,差异均无统计学意义(P=0.427、0.777)。
临床怎么用
- 对于DCIS患者,可结合年龄、首发症状、活检方式及病灶大小个体化选择乳房手术与腋窝评估方式。
- 不同局部治疗方式对DCIS长期生存影响无明显差异,支持在合适患者中考虑保乳手术。
局限性
- 本研究为单中心回顾性分析,随访时间及混杂因素可能影响结果解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the choice of surgical treatment of ductal carcinoma in situ (DCIS) and its impact on long-term outcomes. Methods: A retrospective analysis of the clinicopathological features and treatment protocol of DCIS patients who underwent surgical treatment in Comprehensive Breast Health Center, Ruijin Hospital, Shanghai Jiaotong University School of Medicine from January 2009 to August 2016 was done. The factors which could affect surgical treatment were analyzed by χ(2) test and Logistic regression. Survival analysis were performed between different surgical approaches. Kaplan-Meier survival curves and Log-rank tests demonstrated the distribution of disease free survival and overall survival. Results: A total of 526 patients were enrolled in this study, 405 cases (77.0%) underwent mastectomy, 121 cases (23.0%) underwent breast-conserving surgery, of which 88 cases received radiotherapy after breast-conserving surgery. It was shown by univariate and multivariate analysis that age>50 years (OR=0.631, 95% CI: 0.413 to 0.965, P=0.034), first symptom of nipple discharge (OR=0.316, 95% CI: 0.120 to 0.834, P=0.020), excision biopsy (OR=1.831, 95% CI: 1.182 to 2.835, P=0.007) and tumor size >3 cm (OR=0.422, 95% CI: 0.206 to 0.864, P=0.018) were significantly correlated with choice of surgical treatment for breast lesions. Axillary lymph node dissection was performed for 118 cases (22.4%), with sentinel lymph node biopsy for 327 cases (62.2%), and none for 81 cases (15.4%). There was significant statistical difference in the choice of axillary lymph node management in patients of different age (χ(2)=8.124, P=0.017), biopsy type (χ(2)=35.567, P=0.000), breast operation type (χ(2)=149.118, P=0.000) and tumor size (χ(2)=13.394, P=0.010). The 5-year disease free survival rates was 95.7%, 89.6% and 100%, respectively, for mastectomy group, breast-conserving surgery group and breast-conserving surgery plus radiotherapy group. And the 5-year overall survival rates for three groups were 99.0%, 100% and 100%. The differences were not statistically significant (P=0.427, 0.777). Conclusions: For DCIS patients, age, first symptom and tumor size are independent predictors of breast surgery. The choice of axillary lymph node surgery is influenced by age, biopsy, operation type, and tumor size. Different surgical treatment options has no significant effect on disease-free survival and overall survival in DCIS patients. 目的:分析乳腺导管内癌(DCIS)患者外科治疗方式及其对患者预后的影响。 方法:收集2009年1月至2016年8月于上海交通大学医学院附属瑞金医院乳腺疾病诊治中心进行手术治疗的DCIS患者的临床病理信息,分析DCIS患者外科治疗方式的选择及其影响因素,并进行随访,分析不同手术方式与患者预后的关系。采用χ(2)检验对临床资料进行比较,采用Logistic回归分析进行多因素分析,采用Kaplan-Meier法绘制生存曲线,并用Log-rank法比较生存曲线间的差异。 结果:共526例患者纳入本项研究,405例(77.0%)接受乳房切除术,121例(23.0%)接受保留乳房手术,其中88例在行保留乳房手术后接受放疗。年龄>50岁(OR=0.631,95% CI:0.413~0.965,P=0.034)、首发症状为乳头溢液(OR=0.316,95% CI:0.120~0.834,P=0.020)、切除活检(OR=1.831,95% CI:1.182~2.835,P=0.007)及病灶最大径>3 cm(OR=0.422,95% CI:0.206~0.864,P=0.018)是DCIS患者乳房手术方式的独立预后因素。118例(22.4%)接受了腋窝淋巴结清扫术,327例(62.2%)接受了前哨淋巴结活检术,81例(15.4%)未行腋窝手术,腋窝淋巴结评估方式的选择受患者年龄(χ(2)=8.124,P=0.017)、活检方式(χ(2)=35.567,P=0.000)、乳房手术方式(χ(2)=149.118,P=0.000)及病灶最大径(χ(2)=13.394,P=0.010)的影响。乳房切除术组、保留乳房手术+放疗组、保留乳房手术组5年无病生存率分别为95.7%、89.6%、100%,5年总体生存率分别为99.0%、100%、100%,差异均无统计学意义(P=0.427、0.777)。 结论:年龄、首发症状及病灶最大径是DCIS患者乳房手术方式选择的独立预后因素,腋窝淋巴结评估方式选择则受患者年龄、活检方式、乳房手术方式及病灶最大径的影响。不同的局部治疗方式对DCIS患者无病生存率及总体生存率并无明显影响。.
引用
- Zhu SJ, Chen XS, Wu JY, et al. [Surgical treatment and prognosis of ductal carcinoma in situ: 526 cases analysis]. Zhonghua Wai Ke Za Zhi. 2017. PMID: 28162210. doi:10.3760/cma.j.issn.0529-5815.2017.02.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。